Table 1.
Control | POAG | p* | |
---|---|---|---|
Number of subjects | 22 | 30 | |
Number of eyes | 43 | 57 | |
Age (SEM), year | 66.4 [1.6] | 65.2 [1.5] | 0.599 |
Gender (female:male) | 14:8 | 16:14 | 0.458 |
Systolic pressure (SEM), mmHg | 132.1 [2.1] | 135.0 [1.7] | 0.351 |
DIASTOLIC pressure (SEM), mmHg | 82.6 [2.0] | 82.9 [1.2] | 0.558 |
IOP (SEM), mmHg | 14.3 [0.6] | 12.3 [0.5] | 0.021 |
Cup/disc ratio | 0.4 [0.02] | 0.7 [0.03] | < 0.001 |
Hypertension, n | 2 | 4 | 0.973 |
Cardiovascular diseases, n | 1 | 2 | - |
Diabetes, n | 1 | 1 | - |
Hyperlipidemia, n | 0 | 1 | - |
Depression, n | 2 | 2 | - |
Mean deviation, dB | − 6.3 [0.9] | ||
IOP-lowering eye drop†, n | 1.6 [0.1] |
*Chi-square test for gender analysis, Mann–Whitney U-test for other comparisons between control and glaucoma groups. †One compound eye drop is considered as two types of eye drops